Click here to learn more about our monitoring solutions for symptoms of COVID‑19

Medical Grade Remote Care Is Here.

Introducing the BioSticker
The First FDA-cleared single-use device for up to 30 days of continuous vital signs monitoring

Illuminating Blind Spots in Healthcare that are Costly and Avoidable

>10%
of patients suffer a major postoperative complication
4.3M
patients are readmitted within 30 days of discharge annually
$61.9B
Annual cost of all-cause 30-day readmissions
27%
of 30-day readmissions deemed preventable

A New Era of Continuous Health Monitoring and Clinical Intelligence

The BioIntelliSense Data-as-a-Service (DaaS) platform and FDA-cleared BioSticker™ on-body sensor are bringing medical grade monitoring and management to the home for scalable remote care.

Scalable Remote Care Meets Medical Grade Intelligence

Medical grade continuous monitoring patients can stick with.

The FDA-cleared BioSticker medical device is designed to be discreetly worn on the upper left chest for effortless remote data capture and a simplistic “stick it on and forget it” patient experience. The physician-prescribed BioSticker is the first single-use medical device for up to 30 days of continuous vital sign monitoring.

  • Respiratory rate, heart rate at rest and skin temperature
  • Body position, activity levels, sleep status
  • High-resolution gait analysis and fall detection
  • Symptomatic events

Patient-centered, data driven care built for scale

The BioSticker medical device and advanced data services provide vital sign trending and personalized clinical intelligence via the BioReport.

Learn how BioIntelliSense’s strategic collaboration with UCHealth and its CARE Innovation Center are bringing cost-effective patient monitoring and medical grade care to the home.

Unique Actionable Insights for Proactive Clinical Decisions

Introducing the BioIntelliSense Data-as-a-Service (DaaS) platform offerings:

MedEpoch™ data service

A physician prescribed service leveraging the BioSticker device's large on-board memory to collect continuous patient data for up to a 30-day wear period, providing a high-resolution view of patient trending and health condition.

  • Pre-surgical baseline
  • Pre-operative anesthesia
  • In-home condition management

Remote Patient Monitoring (RPM) data service

A medical grade monitoring service enabling early detection and longitudinal management of a patient’s condition at home through actionable clinical insights at a fraction of the cost of traditional RPM.

  • Chronic and complex care management
  • Post-surgical recovery + rehabilitation
  • Post-hospital virtual care

A New Standard in Remote Patient Monitoring.

Medical-grade data services for continuous monitoring of vital signs, physiological biometrics and symptomatic events

Skin Temperature
 
Heart Rate at Rest
 
Respiratory Rate
at Rest
Gait Analysis
 
Body Position
 
Steps & Activity Level
 
Fall Detection
 
Identity
Management
Sleep
 
Coughing
Frequency  
Sneezing
Frequency  
Vomiting
Frequency  

News + Insights

Learn more about how BioIntelliSense can scale your remote patient monitoring programs.

Our Founders

James Mault, MD, FACS
Founder + CEO

Dr. Mault has more than 35 years of experience in senior executive positions in the health IT and medical device industry as well as clinical medicine. He has founded five health IT and medical device companies, leading these companies to develop novel devices and software technologies, gain FDA approvals and forge strategic partnerships with numerous Fortune 500 companies. He is the named inventor of over 80 issued and pending patents for a variety of health IT and medical device innovations. Dr. Mault received his B.S. in Biology and Medical Degree from the University of Michigan and conducted his General Surgery and Cardiothoracic Surgery residency training at Duke University Medical Center. He has been board-certified in both General Surgery and Cardiothoracic Surgery, having specialized in heart and lung transplantation, thoracic oncology and critical care.

David Wang
Co-Founder + CTO

Dave brings 20 years of experience in product execution and innovation. As the founding CEO of Striiv Corp, he spearheaded all aspects of building and executing seven generations of biometric wearables, shipping millions of devices to customers including United Healthcare, Pfizer, Walgreens, Acer, Best Buy and Qualcomm Life. Dave’s expertise is in building teams while simultaneously building products that combine multiple technology disciplines. Dave graduated from Stanford University with a dual M.S. degree in Electrical Engineering and Management Science and Engineering, and he received a B.S. in Electrical Engineering and Computer Science from UC Berkeley. He also holds over 15 patents in the fields of sensors, algorithms, edge processing and validation.